How should children with hepatitis B virus-related nephritis be treated?
First, treatment
1. General treatment
This includes a low-salt diet, a moderate amount of high-quality protein diet; diuretics should be administered when edema is significant, with various oral diuretics given, and furosemide (furosemide, Lasix) 1-2mg/(kg·time) may be administered intravenously for severe edema; for hypertension, nifedipine (nifedipine,心痛定) 0.25-0.5mg/(kg·time), 3-4 times a day, or ACEI drugs can be taken orally, such as captopril (captopril, thienameth) 1-2mg/(kg·d), 2-3 times a day.
2. Treatment with adrenal cortical hormones and immunosuppression
The treatment with adrenal cortical hormones has always been controversial. Adrenal cortical hormones and immunosuppressants should be avoided as much as possible for children with mild to moderate proteinuria to prevent exacerbation of viral replication. For HBV-GN with a large amount of proteinuria, some people have tried short-term prednisone therapy to reduce proteinuria. However, recent studies believe that HBV-GN has little effect on corticosteroids, and long-term clinical observations show that adrenal cortical hormones are harmful without any benefits. Therefore, it should be prohibited to use adrenal cortical hormones alone for treatment, and immunosuppressants are even more unsuitable for use.
3. Antiviral treatment
There are mainly interferon α (α-interferon), cytosine arabinoside (Ara-A), lamivudine (lamivudine-he), and so on. Currently, interferon α treatment for HBV-GN has achieved significant effects, with excellent long-term effects. The dose is 200,000U/(kg·time) of interferon α, injected intramuscularly or subcutaneously once every other day, and the course of treatment should not be less than half a year. Almost all patients can achieve good efficacy, often promoting the negative conversion of HBeAg around 4 months after medication. A few children may still achieve the negative conversion of HBsAg around 10 months after treatment. Proteinuria can be significantly reduced or significantly improved. Fever and flu-like symptoms may occur in the early stage of injection, which will disappear after a few days. Cytosine arabinoside (Ara-A) is also an antiviral drug, first used by Lin's family in Taiwan for the treatment of HBV-GN, achieving certain efficacy. The dose is 15mg/(kg·d), administered intravenously slowly, with a course of 2 weeks. Thymosin can also be used to enhance efficacy, with a dose of 0.2-0.5mg/(kg·d), once a day, for a course of half a year. The adverse reactions of cytosine arabinoside (Ara-A) are significant, and its efficacy is not as good as interferon α, so it has been replaced by α-INF. Lamivudine is a new nucleic acid antiviral drug, with a daily dose of 100mg orally for older children, for a course of more than half a year. Its efficacy for hepatitis B is close to that of interferon α, and it is used less for the treatment of HBV-GN, with efficacy waiting for more data to be determined.
4. Antithrombotic Drugs
Dipyridamole (dipyridamole; persantin, persantin) 5 to 8mg/(kg·d), 3 times/d, taken orally.
5. Angiotensin Converting Enzyme Inhibitors (ACEI)
Captopril (captopril) can be used at 0.5 to 1mg/(kg·time), 2 to 3 times/d; or enalapril 2.5 to 5mg/time, 2 to 3 times/d; cilazapril 5 to 10mg/d, 1 time/d; fosinopril 5 to 10mg/d, 1 time/d; benazepril 5mg/d, 1 time/d, etc., which have certain effects on reducing proteinuria and protecting the kidneys.
6. Traditional Chinese Medicine and Herbs
Traditional Chinese medicine has certain effects on liver protection and inhibiting HBV proliferation. The author once tried Sanpu hepatitis B healthy, A, B tablets 2 to 3 tablets/time, 3 times/d, treated for 3 to 6 months, with satisfactory results; in addition, it can also be selected to take hepatitis B Ning and hepatitis B detoxification capsules for a long time.
II. Prognosis
There is no specific treatment for this disease, and symptomatic treatment is the main approach. There is controversy regarding the use of hormones and immunosuppressants. However, for patients with nephrotic syndrome, it may be possible to try adrenal cortical hormones under close medical observation. Shanghai Medical University Hospital treated 10 patients with HBV-related nephritis manifesting as nephrotic syndrome with hormones, 7 cases were membranous nephropathy, among which 5 had partial response and 2 were ineffective. However, after 2 to 9 years of follow-up, all 7 cases were relieved, 3 cases of membranoproliferative nephritis were ineffective, including 2 cases with persistent proteinuria for 4 to 9 years and renal insufficiency, and 1 case died of uremia 7 years later. Peking University First Hospital's Department of Pediatrics treated 11 patients with HBV-related nephritis complicated with nephrotic syndrome with prednisone, all showed no effect at 8 weeks, but half of them were relieved after reducing the dose and continuing treatment. The average follow-up was 46.5 months from 10 months to 9.5 years, with 1 case dying of jaundice due to gastrointestinal infection and 1 case developing renal dysfunction at 5 years of disease course, the remaining 9 cases all achieved clinical remission, among which 3 cases had 1 to 3 recurrences during the disease course and were relieved after re-administration of prednisone. The prednisone treatment plan can be referred to primary nephrotic syndrome, but the use of cytotoxic drugs needs to be cautious, as immunosuppressants can accelerate HBV replication and worsen HBV infection.
Therefore, it is best not to use it when there is active hepatitis or HBV replication markers (such as high-titer HBcIgM) or positive HBeAg, for those with abnormal liver function, liver protection therapy can be added, such as glucuronic acid (Gan Tai Le), Yunzhi Gan Tai and various vitamins, etc., the diet should be light, less greasy, pay attention to rest, avoid overwork, regular follow-up, and can also take traditional Chinese medicine treatment. In recent years, interferon therapy can be tried for those with persistent HBsAg positivity, currently the interferon used is mostly genetically engineered interferon, which has antiviral effects, mainly through the binding of interferon to interferon receptors on the cell membrane, inducing a variety of antiviral proteins to hinder the synthesis of viral nucleic acids and proteins, inhibit viral replication, but cannot exclude the virus from the body. In Japan, the interferon administration is 100,000 U/(kg·d) for 28 days continuously or 7 days continuously in the first week, then once every other day, three times a week, for a total of 7 weeks (28 days), the former is more widely used, 11 of 16 cases (62%) became negative within a year after the end of the course, but there was no difference in the conversion rate of serum in adults treated with the same method, China commonly used interferon is 1a, 2b, etc., the dose is 3 million U for adults once, every other day or three times a week; children can use 100U, every other day or three times a week, subcutaneous or intramuscular injection, course of 3 to 6 months, fever may occur at the beginning of treatment, antipyretics can be added if necessary, the recent efficacy (at the end of the course) of HBV-DNA and HBeAg conversion rate is 30% to 50%, and about 25% to 50% of patients relapse within a year after discontinuation of medication, the conversion rate of HBsAg is low.